Ilkka Oyj – Acquisition of own shares on 6 February 2023
ILKKA OYJ, STOCK EXCHANGE RELEASE, 6 February 2023 at 19:00 EET
IlkkaOyj – Acquisition of own shares on 6 February 2023
At Nasdaq Helsinki Ltd:
| Date | 6 February 2023 |
| Exchange transaction | Buy |
| Share trading code | ILKKA2 |
| Amount, shares | 980 |
| Average price/share, EUR | 4.0693 |
| Total cost, EUR | 3,987.91 |
The company holds a total of 47,186 of its own shares (ILKKA2) including the shares acquired on 6 February 2023.
Detailed information concerning the acquisition is attached to this stock exchange release.
On behalf of Ilkka Oyj
DANSKE BANK A/S, FINLAND BRANCH
Jonathan Nyberg Antti Väliaho
Additional information
Olli Pirhonen, CEO, Ilkka Oyj, tel. +358 40 766 5418
Attachment
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
GlobeNewswire by notifiedGlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Storaktionærmeddelelse30.3.2023 09:40:36 CEST | pressemeddelelse
Årets meddelelse nr. 21 Dato: 30. marts 2023 Storaktionærmeddelelse Det skal herved meddeles, at Pharma Equity Group A/S dags dato har modtaget meddelelse om at BioPharma Holding ApS ejerandel, efter kapitalforhøjelse offentliggjort under selskabsmeddelelse nr. 16 af 24. marts 2023, udgør 20,05 % af stemme – og aktiekapitalen i Pharma Equity Group A/S, svarende til nominelt 205.121.015 stk. aktier. Alle henvendelser vedrørende ovenstående bedes venligst rettet til direktør Peter Ole Jensen på e-mail: peter.ole.jensen@pharmaequitygroup.com. Med venlig hilsen Pharma Equity Group A/S På bestyrelsens vegne
DSV – Q1 2023 analyst conference call30.3.2023 09:34:08 CEST | Press release
We expect to release the Q1 2023 results of DSV A/S in the morning of 27 April 2023. A webcast and conference call will be held at 11:00 am CEST. At the call, Group CEO Jens Bjørn Andersen, Group COO Jens Lund and Group CFO Michael Ebbe will present the Q1 2023 Interim Financial Report. The presentation will be followed by a Q&A session. Date: 27 April 2023 Time: 11:00 am CEST To attend the conference call, you may do one of the following: a. Webcast Go to investor.dsv.com or https://dsv-events.eventcdn.net/events/interim-report-first-quarter-2023 b. Conference call Participant dial-in telephone numbers: DK: +45 78 76 84 90 UK: +44 (0) 203 769 6819 US: +1 646 787 0157 (PIN 882 686) We recommend participants to dial in 10 minutes prior to the scheduled start time. Contacts Investor Relations Flemming Ole Nielsen, tel. +45 43 20 33 92, flemming.o.nielsen@dsv.com Media Christian Krogslund, tel. +45 43 20 41 28, christian.krogslund@dsv.com Yours sincerely, DSV A/S Attachment Investor news
Indberetning af ledende medarbejderes og disses nærtståendes transaktioner med A.P. Møller - Mærsk A/S aktier i forbindelse med aktietilbagekøbsprogram30.3.2023 09:17:43 CEST | pressemeddelelse
I forbindelse med det annoncerede aktietilbagekøbsprogram i A.P. Møller - Mærsk A/S sælger A.P. Møller Holding A/S løbende aktier pro rata og markedet informeres følgeligt herom - se vedhæftede fil. Vedhæftet fil APMM Aktietilbagekøbsprogram APMH salg_29032023
Notification of managers and closely related parties’ transactions with A.P. Møller - Mærsk A/S shares in connection with share buy-back program30.3.2023 09:17:43 CEST | Press release
In connection with the announced share buy-back program in A.P. Møller - Mærsk A/S, A.P. Møller Holding A/S continuously sells shares pro rata and the market is to be informed accordingly – see the attached file. Attachment APMM Share buy-back APMH sale 29032023
Systemic risk buffer requirement set to MuniFin30.3.2023 09:00:00 CEST | Press release
Municipality Finance Plc Stock exchange release 30 March 2023 at 10.00 am (EEST) Systemic risk buffer requirement set to MuniFin On 29 March 2023, the Finnish Financial Supervisory Authority (FIN-FSA) has, in accordance with the sections 4a and b, Chapter 10 of the act on Credit Institutions, set a systemic risk buffer requirement of 1.0 per cent to MuniFin. The decision will take effect on 1 April 2024, and it is equivalent to the requirements set to other Finnish banks at the same time. MuniFin clearly meets all capital requirements set to it. MUNICIPALITY FINANCE PLC Esa Kallio President and CEO tel. +358 50 337 7953 MuniFin (Municipality Finance Plc) is one of Finland’s largest credit institutions. The owners of the company include Finnish municipalities, the public sector pension fund Keva and the Republic of Finland. MuniFin Group also includes the subsidiary company, Financial Advisory Services Inspira Ltd. The Group’s balance sheet totals close to EUR 48 billion. MuniFin builds